deferasirox "stada" 90 mg filmovertrukne tabletter
stada arzneimittel ag - deferasirox - filmovertrukne tabletter - 90 mg
deferasirox "sandoz" 90 mg filmovertrukne tabletter
sandoz a/s - deferasirox - filmovertrukne tabletter - 90 mg
deferasirox "medical valley" 90 mg filmovertrukne tabletter
medical valley invest ab - deferasirox - filmovertrukne tabletter - 90 mg
deferasirox "pharmathen" 90 mg filmovertrukne tabletter
pharmathen s.a. - deferasirox - filmovertrukne tabletter - 90 mg
deferasirox "glenmark" 90 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - deferasirox - filmovertrukne tabletter - 90 mg
citrafleet 0,01+3,5+10,97g pulver til oral opløsning, breve
casen recordati, s.l. - citronsyre, vandfri, magnesiumoxid, let, natriumpicosulfat - pulver til oral opløsning, breve - 0,01+3,5+10,97g
citrafleet 0,01g+3,5g+10,97g pulver til oral opløsning, breve
2care4 aps - citronsyre, vandfri, magnesiumoxid, let, natriumpicosulfat - pulver til oral opløsning, breve - 0,01g+3,5g+10,97g
picoprep 10 mg+3,5 g+12 g pulver til oral opløsning
europharma.dk aps - citronsyre, vandfri, magnesiumoxid, let, natriumpicosulfat - pulver til oral opløsning - 10 mg+3,5 g+12 g
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
arcoxia 120 mg filmovertrukne tabletter
n.v. organon - etoricoxib - filmovertrukne tabletter - 120 mg